Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    2736
    PDF: 1300
    HTML: 1117
  • ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

    Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca
    e2020075
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.075
    1808
    PDF: 1532
    HTML: 660
  • NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis

    alvisa palese, chiara visintini, margherita venturini, gianpaolo gargiulo, stefano botti
    e2019051
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.051
    2295
    PDF: 1150
    HTML: 335
  • MALARIA IN CHILDREN

    Richard-Fabian Schumacher, Elena Spinelli
    e2012073
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.073
    5790
    PDF: 2943
    HTML: 7587
  • Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy

    Claudio Ucciferri, Alessandro Occhionero, Jacopo Vecchiet, Katia Falasca
    e2018069
    2018-10-29
    https://doi.org/10.4084/mjhid.2018.069
    1730
    PDF: 1050
    HTML: 244
  • ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS

    Lourdes Vazquez
    e2016040
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.040
    4510
    PDF: 1477
    HTML: 2213
  • NOVEL DRUGS IN FOLLICULAR LYMPHOMA

    Giuseppe Rossi, Antonella Anastasia
    e2016061
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.061
    6005
    PDF: 1626
    HTML: 1689
    Untitled: 287
  • CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

    Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda
    e2019067
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.067
    3224
    PDF: 1962
    HTML: 973
  • A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery

    Matteo D'Addona, Luca Pezzullo, Corradino Campisi, Corrado Cesare Campisi, Valentina Giudice, Vincenzo Ciccone, Roberto Guariglia, Bianca Serio, Carmine Selleri
    e2023063
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.063
    823
    PDF: 495
    HTML: 176
  • MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

    Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo
    e2025064
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.064
    2740
    PDF: 1083
    HTML: 338
  • Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

    Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda
    e2025026
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.026
    2162
    PDF: 1802
    HTML: 492
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

    Fabienne McClanahan, Peter Dreger
    e2012071
    2012-11-06
    https://doi.org/10.4084/mjhid.2012.071
    2650
    PDF: 903
    HTML: 1791
  • Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature

    Matteo Chinello, Daniela Di Carlo, Francesca Olivieri, Rita Balter, Massimiliano De Bortoli, Virginia Vitale, Ada Zaccaron, Elisa Bonetti, Alice Parisi, Simone Cesaro
    e2018043
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.043
    2769
    PDF: 1154
    HTML: 395
  • CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Ahmet Yigitbasi, Elif Gulsum Umit, Ufuk Demirci, Guray Aygun, Nese Varli, Elif Aksoy, Fehmi Hindilerden, Emine Gulturk, Eren Arslan Davulcu, Ahmet Muzaffer Demir
    e2026027
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.027
    1079
    PDF: 930
    HTML: 221
  • THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.

    Pau Montesinos, Miguel A Sanz
    e2011059
    2011-12-04
    https://doi.org/10.4084/mjhid.2011.059
    3512
    PDF: 1679
    HTML: 3061
  • UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

    Patrizia Tosi, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Annalia Molinari, Serena Mangianti, Marina Ratta, Alessandro Isidori, Giuseppe Visani
    e2012069
    2012-11-05
    https://doi.org/10.4084/mjhid.2012.069
    2710
    PDF: 810
    HTML: 1660
  • LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE

    Patrizia Tosi
    e2013037
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.037
    1489
    PDF: 992
    HTML: 1312
    fig 1A: 240
    figure1B: 206
  • ASSOCIATION OF VDBP RS4701 VARIANT, BUT NOT VDR/RXR-? OVER-EXPRESSION WITH BONE MINERAL DENSITY IN PEDIATRIC ?-THALASSEMIA PATIENTS Vitamin D metabolic axis and BMD in ?-thalassemia

    Shaimaa Sahmoud, Mostafa S. Ibrahim, Eman A. Toraih, Noha Kamel, Manal Fawzy, Samar Elfiky
    e2020037
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.037
    1430
    PDF: 807
    HTML: 302
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4382
    PDF: 1319
    HTML: 1498
  • Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis

    Fabiana Gentilini, Anna Levi, Vincenzo Federico, Eleonora Russo, Robin Foà, Maria Teresa Petrucci
    e2012035
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.035
    1780
    PDF: 830
    HTML: 678
  • SOCIAL AND FINANCIAL BARRIERS TO OPTIMUM TKI TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA- A KNOWLEDGE-ATTITUDES-PRACTICES STUDY FROM INDIA

    Naveen Gupta, Manoranjan Mahapatra, Tulika Seth, Seema Tyagi, Sudha Sazawal, Renu Saxena
    e2021004
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.004
    2355
    PDF: 685
    HTML: 333
  • CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

    Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2024012
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.012
    2545
    PDF: 1989
    HTML: 194
  • The COST-UTILITY ANALYSIS OF FOUR CHELATION REGIMENS FOR ?-THALASSEMIA MAJOR: A CHINESE PERSPECTIVE

    Jialian Li
    e2020029
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.029
    2085
    PDF: 1058
    HTML: 416
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1773
    HTML: 722
    PDF: 933
  • PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Isidro Jarque, Miguel Salavert, Javier Pemán
    e2016035
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.035
    3914
    PDF: 1370
    HTML: 3976
    Untitled: 289
    Untitled: 320
  • TREATMENT OF NEWLY DIAGNOSED POEMS SYNDROME: BORTEZOMIB OR LENALIDOMIDE? EXPERIENCE FROM TWO COUNTRIES

    Deniz Ozmen, Francesco Autore, Tuba Ozkan, Gunel Musayeva, Zeliha Birsin, Daniele Mannina, Federica Lessi, Daniele Derudas, Umut Yilmaz, Tugrul Elverdi, Ahmet Emre Eskazan, Muhlis Cem Ar, Zafer Baslar, Stefania Bramanti, Luca Laurenti, Ayse Salihoglu
    e2026084
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.084
    74
    PDF: 36
    Suppl. Files: 16
    Html: 14
    Html Suppl. Files: 4
  • Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.

    Giuseppe Vittorio De Socio, Gianluigi Fabbriciani, Marco Massarotti, Salvatore Messina, Enisia Cecchini, Bianca Marasini
    e2012025
    2012-05-04
    https://doi.org/10.4084/mjhid.2012.025
    1545
    PDF: 960
    HTML: 10125
    cover letter to the editor: 217
    tile page: 299
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    3201
    PDF: 3437
    HTML: 809
  • COMPARISON OF EMPIRIC ANTIBIOTIC ESCALATION THERAPY WITH VANCOMYCIN (VAN) VERSUS LINEZOLID (LIN) IN PATIENTS WITH FEBRILE NEUTROPENIA

    Karin Mayer, Nicolaus Hegge, Ernst Molitor, Peter Brossart, Corinna Hahn-Ast
    e2022032
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.032
    1265
    PDF: 632
    HTML: 274
  • ADVANCES IN THE TREATMENT OF MALARIA

    Francesco Castelli, Lina Rachele Tomasoni, Alberto Matteelli
    e2012064
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.064
    2997
    PDF: 1393
    HTML: 6165
  • Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia

    Kun Yang
    e2025037
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.037
    1019
    PDF: 815
    HTML: 292
  • EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

    Pellegrino Musto, Dr. Nicola Sgherza
    e2024073
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.073
    1711
    PDF: 921
    HTML: 373
  • Counting the Cost: How Anticipating Financial Burden Affects Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma

    Fabio Guolo, Paola Del Sette, Francesca Riccardi, Paola Minetto, Andrea Todiere, Filippo Ballerini, Carola Riva, Michele Cea, Roberto Massimo Lemoli, Elena Sarcletti
    e2026029
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.029
    562
    PDF: 479
    HTML: 115
  • The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY

    Sarah Liptrott, Mairéad NíChonghaile, Liz O'Connell, Erik Aerts
    e2023033
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.033
    2279
    Suppl. Files: 993
    HTML: 620
    PDF: 861
  • Graves’ disease thyrotoxicosis and propylthiouracil related agranulocytosis successfully treated with therapeutic plasma exchange and g-csf followed by total thyroidectomy.

    Anna Candoni
    e2017058
    2017-10-16
    https://doi.org/10.4084/mjhid.2017.058
    3129
    PDF: 960
    HTML: 1450
    Fig.1: 223
    Fig.2: 223
  • ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS

    Alessandro Busca, Livio Pagano
    e2016039
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.039
    5010
    PDF: 1643
    HTML: 2289
    Untitled: 280
    Untitled: 300
    Untitled: 317
    Untitled: 273
    Untitled: 284
  • How I treat acute and persistent sickle cell pain

    Samir Ballas
    e2020064
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.064
    2176
    PDF: 1209
    HTML: 805
  • IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

    Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria
    e2024060
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.060
    2740
    PDF: 2003
    HTML: 191
  • WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

    Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi
    e2018004
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.004
    7999
    PDF: 2543
    HTML: 2180
    Table 1.: 278
    Table 2.: 299
    Table 3.: 271
    Table 4.: 271
  • EFFECT OF NEBULIZED COLISTIN ON THE VENTILATOR CIRCUIT: A PROSPECTIVE PILOT CASE-CONTROL STUDY FROM A SINGLE CANCER CENTER

    Iyad M Ghonimat, Lama H Nazer, Flsteen Aqel, Mohammad K Mohammad, Feras I Hawari, Jennifer Le
    e2015032
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.032
    1862
    PDF: 891
    HTML: 1863
  • THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM

    May Basood, Howard S. Oster, Moshe Mittelman
    e2018046
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.046
    3409
    PDF: 1489
    HTML: 753
  • Transfusion-related acute lung injury (TRALI) in two thalassaemia patients caused by the same multiparous blood donor

    George J Kontoghiorghes
    e2017060
    2017-10-18
    https://doi.org/10.4084/mjhid.2017.060
    2489
    PDF: 735
    HTML: 889
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    6577
    PDF: 2503
    HTML: 1586
  • HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré
    e2014050
    2014-07-01
    https://doi.org/10.4084/mjhid.2014.050
    3100
    PDF: 1472
    HTML: 3746
    Untitled: 264
    Untitled: 266
    Untitled: 221
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1335
    PDF: 592
    HTML: 1725
    Figures: 215
    Fifures Sanz: 224
    tables Sanz: 228
    Untitled: 224
  • Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience

    Roberta Laureana
    e2026090
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.090
    81
    PDF: 31
    Html: 12
  • DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE

    Ibrahim C. Haznedaroglu
    e2015014
    2015-12-02
    https://doi.org/10.4084/mjhid.2015.014
    277953
    PDF: 1918
    HTML: 3917
  • TREATMENT OF ADOLESCENT AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Josep-Maria Ribera, Jordi Ribera, Eulàlia Genescà
    e2014052
    2014-07-02
    https://doi.org/10.4084/mjhid.2014.052
    2931
    PDF: 1472
    HTML: 6113
  • MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

    Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan
    e2015001
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.001
    2521
    PDF: 1410
    HTML: 17242
    Bassan Fig.1: 188
    Bassan Fig.2: 292
    Bassan Fig.4: 176
    Fig.3: 311
  • IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA

    Ugo Testa, Prof. Leone, Dr. Elvira Pelosi, Dr. Germana Castelli, Prof, Valerio De Stefano
    e2024044
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.044
    2733
    PDF: 1267
    HTML: 178
101 - 150 of 256 items << < 1 2 3 4 5 6 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.